Here's why Ramsay Health Care Limited is a buy and hold forever stock

Ramsay Health Care Limited (ASX:RHC) has held an upbeat AGM.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Private hospital operator Ramsay Health Care Limited (ASX: RHC) held its annual general meeting (AGM) on Thursday and once again the company reminded investors just why it has been such an outstanding success.

With a total shareholder return (TSR) of 25.8% per annum since listing on the ASX in September 1997, there is little doubt as to the investment merits of this company.

Here are some of Ramsay's key attributes:

  • 212 hospitals across five countries
  • Employs 60,000 people
  • Admits around 3 million patients per year
  • Still expanding profits – the group managed to increase its earnings before interest, tax, depreciation, amortisation and rent (EBITDAR) margin from 18.2% to 19.2%

Here's why you could probably hold the stock forever

The global industry dynamics are incredibly favourable for the health care sector with the global population aged over 60 set to more than triple between now and 2050.

Ramsay holds an appealing mix of brownfield developments complemented by numerous greenfield developments and acquisition opportunities as well. There are 8 main brownfield projects due to complete in 2016 that will add around 450 beds across the group. Meanwhile, a significant merger in France has propelled the group to the position of leading private hospital operator in the country. Perhaps most exciting of all, however, is the greenfield opportunity in the form of China where Ramsay recently announced its entry into the region via a joint venture.

Core earnings per share in financial year 2015 grew 20% to 196.6 cents per share. For the current financial year, investors have been guided by the company to expect core EPS growth of between 12% and 14%.

With the stock trading at $64.38, representing a trailing P/E ratio of 32.7x, investors buying in today are certainly paying a hefty premium however, if you take a very long-term view, that premium could be justified.

Motley Fool contributor Tim McArthur has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »